Ted Chu is the Senior Vice President of Global Research and Development at Multitude Therapeutics, an expert in Antibody-Drug Conjugates (ADCs). With a PhD from The University of Texas at Austin, he has extensive experience leading ADC projects, cell therapy development, and biologics manufacturing, driving multiple programs from research to clinical supply.
He has successfully driven over 20 regulatory filings (INDs, BLAs, MAAs) with global agencies, including the FDA and EMA.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.